Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2802
http://purl.obolibrary.org/obo/NCIT_C2802
|
|---|---|
| Preferred Name | Ras Peptide ASP |
| Definitions |
A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to aspartic acid) with potential antineoplastic activity. Vaccination with ras peptide Asp may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for this ras mutation, resulting in decreased tumor growth. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to aspartic acid) with potential antineoplastic activity. Vaccination with ras peptide Asp may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for this ras mutation, resulting in decreased tumor growth. (NCI04) |
|---|---|
| prefLabel | Ras Peptide ASP
|
| label | Ras Peptide ASP
|
| code | C2802
|
| prefixIRI | NCIT:C2802
|
| in_subset | |
| Preferred_Name | Ras Peptide ASP
|
| Maps_To | Ras Peptide ASP
|
| NSC Number | 667938
|
| Legacy Concept Name | Ras_Peptide_ASP
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C1514728
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |